Centhaquine: A new resuscitative agent for haemorrhagic shock

blood cells in an ordered row

Triggered by severe blood loss, haemorrhagic shock is a type of hypovolemic shock, an often-fatal condition. Treatments are available but haven’t been updated for a long time – there is a need for a new resuscitative agent to help patients survive and recover. Luckily, Dr Anil Gulati, of Pharmazz, Inc., has developed centhaquine, aka Lyfaquin®. This drug has shown very […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at audience@researchoutreach.org at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION